This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
As Invitrogen seeks to rebound from a year made difficult primarily by the large number of acquisitions it made in 2004 and 2005, a company official said this week that the firm would not shy away from acquisitions, though they would be fewer and smaller than in the past.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

The Wall Street Journal looks into the cost of new gene therapies.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.